B-Cell Non-Hodgkin Lymphoma (NHL)
6 clinical trials · Condition
◉ Watch B-Cell Non-Hodgkin Lymphoma (NHL)
| Record | Firm | Date |
|---|---|---|
| Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma (NCT02920697) | Institut de Recherches Internationales Servier | 2014-03-01 |
| Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL (NCT01994382) | Alexion Pharmaceuticals, Inc. | 2013-08-30 |
| A Compassionate Use (CU) Program of Odronextamab (NCT05619367) | Regeneron Pharmaceuticals |
Track B-Cell Non-Hodgkin Lymphoma (NHL) automatically
Every clearance here is in the API, with alerts when new ones post.